Page last updated: 2024-08-26

propionylcarnitine and Arteriosclerosis

propionylcarnitine has been researched along with Arteriosclerosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Angelis, C; Marino, B; Mauriello, A; Orlandi, A; Ramacci, MT; Spagnoli, LG	1
Di Pino, L; Digrandi, D; Malaponte, G; Mazzarino, MC; Pennisi, G; Signorelli, SS	1
Coto, V; D'Alessandro, L; Grattarola, G; Imparato, L; Lingetti, M; Mancini, M; Nolfe, G; Rengo, F	1

Trials

2 trial(s) available for propionylcarnitine and Arteriosclerosis

Article	Year
Effects of ischaemic stress on leukocyte activation processes in patients with chronic peripheral occlusive arterial disease: role of L-propionyl carnitine administration. Pharmacological research, 2001, Volume: 44, Issue:4 Topics: Aged; Arteriosclerosis; Cardiotonic Agents; Carnitine; Cell Adhesion Molecules; Chronic Disease; E-Selectin; Exercise; Exercise Test; Humans; Intercellular Adhesion Molecule-1; Ischemia; L-Selectin; Middle Aged; P-Selectin; Vascular Cell Adhesion Molecule-1	2001
Evaluation of the therapeutic efficacy and tolerability of levocarnitine propionyl in the treatment of chronic obstructive arteriopathies of the lower extremities: a multicentre controlled study vs. placebo. Drugs under experimental and clinical research, 1992, Volume: 18, Issue:1 Topics: Administration, Oral; Aged; Analysis of Variance; Arterial Occlusive Diseases; Arteriosclerosis; Carnitine; Diabetic Angiopathies; Female; Humans; Intermittent Claudication; Male; Middle Aged; Patient Compliance; Regression Analysis; Stereoisomerism	1992

Article

Year

Effects of ischaemic stress on leukocyte activation processes in patients with chronic peripheral occlusive arterial disease: role of L-propionyl carnitine administration.

Pharmacological research, 2001, Volume: 44, Issue:4

Topics: Aged; Arteriosclerosis; Cardiotonic Agents; Carnitine; Cell Adhesion Molecules; Chronic Disease; E-Selectin; Exercise; Exercise Test; Humans; Intercellular Adhesion Molecule-1; Ischemia; L-Selectin; Middle Aged; P-Selectin; Vascular Cell Adhesion Molecule-1

2001

Evaluation of the therapeutic efficacy and tolerability of levocarnitine propionyl in the treatment of chronic obstructive arteriopathies of the lower extremities: a multicentre controlled study vs. placebo.

Drugs under experimental and clinical research, 1992, Volume: 18, Issue:1

Topics: Administration, Oral; Aged; Analysis of Variance; Arterial Occlusive Diseases; Arteriosclerosis; Carnitine; Diabetic Angiopathies; Female; Humans; Intermittent Claudication; Male; Middle Aged; Patient Compliance; Regression Analysis; Stereoisomerism

1992

Other Studies

1 other study(ies) available for propionylcarnitine and Arteriosclerosis

Article	Year
Propionyl-L-carnitine prevents the progression of atherosclerotic lesions in aged hyperlipemic rabbits. Atherosclerosis, 1995, Apr-07, Volume: 114, Issue:1 Topics: Aging; Animals; Arteriosclerosis; Carnitine; Cell Division; Diet; Disease Models, Animal; Female; Foam Cells; Hyperlipidemias; Immunohistochemistry; Lipoproteins, VLDL; Male; Muscle, Smooth, Vascular; Rabbits	1995